Sage Therapeutics Inc Stock, NASDAQ:SAGE
215 1st Street, Cambridge, Massachusetts 02142
United States of America
Number of Employees: 471
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders of the brain with three key focus areas: depression, neurology, and neuropsychiatry. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.